SCHEMBL9194

SCHEMBL9194

[CH]1CCOC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6523236 1.00
SCHEMBL29187485 0.96
SCHEMBL17222299 0.87
SCHEMBL4358871 0.87
SCHEMBL974514 0.86
SCHEMBL20142385 0.79
SCHEMBL420475 0.76
SCHEMBL5257658 0.75
SCHEMBL19584979 0.75
SCHEMBL5856159 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 26465 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4399209-A1 NEW QUINOLINE DERIVATIVES Elanco Animal Health GmbH (DE) 2024-07-17 EP claimed
US-20240228468-A1 N-(6-((OCTAHYDROCYCLOPENTA[C]PYRROL-5-YI)AMINO)PYRIDAZIN-3-YL)PHENYL)CARBOXAMIDE AND (6- ((OCTAHYDROCYCLOPENTA[C]PYRROL-5-YL)AMINO)PYRIDAZIN-3-YL)BENZAMIDE DERIVATIVES AS MACHR M4 ANTAGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS VANDERBILT UNIVERSITY 2024-07-11 US claimed
US-20240217968-A1 PHARMACEUTICAL COMPOUND Duke Street Bio Limited (GB) 2024-07-04 US claimed
WO-2024131265-A1 COMPOUND FOR TREATING PI3Kγ-MEDIATED DISEASES AND USE THEREOF 中国科学院合肥物质科学研究院 2024-06-27 WO claimed
EP-4389733-A1 METHOD FOR PREPARING 5-BROMO-2-CHLORO-BENZOIC ACID AS RAW MATERIAL IN HYPOGLYCEMIC DRUG SYNTHESIS Zhejiang Ausun Pharmaceutical Co., Ltd. (CN) 2024-06-26 EP claimed
CN-118239953-A Compounds for the treatment of PI3K gamma mediated diseases and uses thereof 中国科学院合肥物质科学研究院 2024-06-25 CN claimed
CN-112533917-B Morpholine derivatives as inhibitors of VPS34 神经孔疗法股份有限公司 2024-06-21 CN claimed
US-20240197888-A1 SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS BIOTHERYX, INC. 2024-06-20 US claimed
EP-4384177-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2024-06-19 EP claimed
EP-4384516-A1 AMINOARYL-INTEGRIN AGONISTS COMPOUNDS Texas Heart Institute (US) 2024-06-19 EP claimed
EP-0069068-B1 HYDROQUINONES AND THEIR PREPARATION CIBA-GEIGY AG (CH) 1984-10-10 EP claimed
US-4430425-A HYDROQUINONE DERIVATIVES CIBA-GEIGY AG (CH) 1984-02-07 US claimed
EP-0098241-A1 Hydroquinone ethers and a process for preparing them CIBA-GEIGY AG (CH) 1984-01-11 EP claimed
EP-0085028-A2 N-Phenylsulfonyl-N'-pyrimidinyl and triazinyl ureas CIBA-GEIGY AG (CH) 1983-08-03 EP claimed
EP-0079772-A2 Herbicidally active 1-(2-oximo-phenyl)-3-heterocyclyl urea derivatives PPG INDUSTRIES, INC. (US) 1983-05-25 EP claimed
EP-0078663-A2 Fungicidal N-phenylcarbamates SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1983-05-11 EP claimed
EP-0069068-A1 Hydroquinones and their preparation CIBA-GEIGY AG (CH) 1983-01-05 EP claimed
EP-0069070-A1 Colour photographic materials containing stabilizers CIBA-GEIGY AG (CH) 1983-01-05 EP claimed
EP-0004435-B1 ETHERS OF 4-HALOMETHYLPYRIDINES, FUNGICIDAL COMPOSITIONS AND METHOD FOR PROTECTING PLANTS FROM FUNGAL DISEASE THE DOW CHEMICAL COMPANY (US) 1981-07-01 EP claimed
US-4186129-A CENTRAL NERVOUS SYSTEM DEPRESSANTS, ANTICONVULSANTS SCHERING AKTIENGESELLSCHAFT (DE) 1980-01-29 US claimed